Skip to main content

The profiles of microRNAs from urinary extracellular vesicles (EVs) prepared by various isolation methods and their correlation with serum EV microRNAs.

Park S, Lee K, Park IB, Kim NH, Cho S, Rhee WJ, Oh Y, Choi J, Nam S, Lee DH

Publication: Diabetes Res Clin Pract (2020) • Vol 160 • Page 108010PMID: 31987752View on PubMed

Purpose

This paper compared the yield, size distribution, microRNA (miRNA, miR) profile, and CD-9 and TSG-101 expression of extracellular vesicles isolated from urine using four methods. The miRNA profile was compared to that in serum from the same patients.

Conclusion

The size distribution and concentration of the particles differed among the methods with the highest yield of particles and RNA obtained when EVs were isolated using ultracentrifugation. Significantly more miRNA species were identified and more miRNA reads mapped when EVs were isolated from urine using ultracentrifugation or qEV columns than using the ExoQuick Kit. miRNA expression levels were strongly to very strongly correlated across isolation methods. Using Western blot bands, the exosomal markers CD-9 and TSG-101 were strongly to very strongly correlated for two patients across the ultracentrifugation, qEV columns, and Exoquick methods for all patients (r=0.83-0.99) but correlations between Amicon 10K and the other three methods varied among the patients. A total of 84 miRNAs were found in both the urine EVs and serum from all three patients, only five of which showed differential expression in serum and urine EVs. Correlations in miRNA expression among patients were stronger for both urine and serum than they were between serum and urine of a single patient.

Studies (1)

Purpose

This study compared the yield, size distribution, miRNA profile, and CD-9 and TSG-101 expression of extracellular vesicles isolated from urine using four methods. The miRNA profile was compared to that in serum from the same patients. Entire early morning urine and serum were collected from four patients with type-2 diabetes, aliquoted, and immediately stored at -80°C (details of blood processing not provided). Extracellular vesicles were isolated from urine by ultracentrifugation, qEV original size exclusion columns (qEV), ExoQuick-TC Plus, and ultrafiltration using Amicon 10K and 100K Ultra Centrifugal Filter devices. Ultracentrifugation involved centrifugation at 2000 x g for 15 min, centrifugation of the supernatant at 13,500 x g for 20 min at 4°C, filtration of the supernatant through a 0.22 µm filter, and centrifugation at 200,000 x g for 65 min at 4°C followed by resuspension of the exosomes in PBS. Size-exclusion chromatography involved centrifugation of the urine at 300 x g for 10 min, centrifugation of the supernatant at 17,000 x g for 20 min, addition of dithiothreitol (dTT) to the supernatant and incubation for 10 min at 37°C, centrifugation at 17,000 x g for 20 min at 4°C, filtration of the supernatant through a 0.22 µm filter, concentration using 10K or 100 K Amicon Ultra Centrifugal Filter devices, application of the concentrated urine on a qEV Size-Exclusion Column, aliquots of eluate were pooled and stored at -80°C. EV precipitation was performed by vortexing, followed by centrifugation at 2000 x g for 15 min followed by EV precipitation using the ExoQuick-TC Plus Kit following the manufacturer’s guidelines and stored at -80°C. Ultrafiltration consisted of vortexing for 90 s, centrifugation at 2000 x g for 15 min, centrifugation of the supernatant at 13,500 x g for 20 min at 4°C, filtration of the supernatant through a 0.22 µm filter, repeatedly placed on 10K or 100K Amicon Ultra Centrifugal Filter devices and centrifuged at 4000 x g for 10 min until concentrated to 400 µL and then stored at -80°C. The size and concentration of EVs was evaluated using Nanoparticle tracking analysis. CD-9 and TSG101 were quantified by Western Blot. RNAs were extracted using miRNeasy. RNA yield and size were evaluated using the Agilent RNA 6000 Pico and Small RNA Kits on a bioanalyzer. Sequencing libraries were constructed using the SMARTer smRNA-Seq Kit, gel-purified, quantified by KAPA Library Quantification Kit, qualified using a TapeStation, pooled, and 101 bp paired-end sequenced on a HiSeq 2500.

Summary of Findings

The size distribution and concentration of the EV particles differed among the methods with the largest size distribution obtained using ultracentrifugation. Further, a mean of 1.51 x 109 particles/ml and 147.8 ng RNA were obtained when EVs were purified using ultracentrifugation but only 7.32 x 109 particles/ml and 21.5 ng RNA and 0.99 x 109 particles/ml and 92.3 ng RNA were obtained when EVs were purified using the qEV columns and the ExoQuick Kit, respectively. RNA extracted from EVs isolated using each of the methods was free from large DNA fragments. Significantly more miRNA species were found when EVs were isolated using ultracentrifugation or qEV columns than using the ExoQuick Kit (mean of 233 and 230 miRNAs, respectively; versus 103 miRNAs, P<0.05, both). A total of 22 miRNAs were detected in all specimens regardless of patient and EV isolation method with an additional 37 found when EV isolation was with ultracentrifugation or qEV columns. Compared to the ExoQuick Kit, more reads mapped to miRNA when EV isolation was with ultracentrifugation (45.0 x 103 versus 10.8 x 103, P<0.05) or qEV columns (36.5 x 103 versus 10.8 x 103, not significant). miRNA expression levels were strongly to very strongly correlated across EV isolation methods (r=0.83-0.99). Further, heatmaps of normalized levels of the 22 common miRNAs showed similar expression patterns and 14 of these miRNAs were shown to regulate CD-9 and TSG-101. Using Western blot bands, the exosomal markers CD-9 and TSG-101 were strongly to very strongly correlated for two patients across the ultracentrifugation, qEV columns, and Exoquick methods for all patients (r=0.83-0.99) but correlations between Amicon 10K and the other three methods were strong to very strong for two patients (r=0.86-0.95), modest for one patient (r=0.64-0.66), and weak for the final patient (r=0.19-0.33). A total of 84 miRNAs were found in both the urine EVs and serum from all three patients. Of these 84, only five (let-7b-5p, let-7f-5p, let-7a-5p, miR-92a-3p, and miR-423-5p) showed differential expression in serum and urine EVs. Correlations in miRNA expression among patients were stronger for both urine (r=0.97-0.99) and serum (r=0.88-0.94) than they were between serum and urine of a single patient (r=0.31-0.72).

  • Biospecimens

    FluidUrine
    FluidSerum
  • Preservation Types

    Frozen
  • Diagnoses

    Diabetes Type 2
  • Platforms

    ProteinWestern blot
    RNAAutomated electrophoresis/Bioanalyzer
    RNANext generation sequencing
    MorphologyLight scattering
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionBiospecimen location
    Serum
    Urine
    Analyte Extraction and PurificationAnalyte isolation method
    ExoQuick-TC Plus
    Ultracentrifugation
    Ultrafiltration using Amicon 10 K and 100 K Ultra centrifugal filter devices
    qEV original size exclusion columns
    Western blot SpecificTargeted peptide/protein
    CD-9
    TSG-101